Ingredient consistency of commercially available polyphenol and tocopherol nutraceuticals

Pharmaceutics

Volumn 2, Issue 1, 2010, Pages 50-60

  Remsberg, Connie M ^a   Good, Renee L ^a   Davies, Neal M ^a  

^a WASHINGTON STATE UNIVERSITY   (United States)

Author keywords

Content analysis; Myricetin; Nutraceuticals; Phloretin; Polyphenols; Pterostilbene; Vitamin E succinate

Indexed keywords

ALPHA TOCOPHEROL SUCCINATE; MYRICETIN; NUTRACEUTICAL; PHLORETIN; POLYPHENOL; PTEROSTILBENE; UNCLASSIFIED DRUG;

ARTICLE; CONTENT ANALYSIS; DIET SUPPLEMENTATION; DRUG DETERMINATION; DRUG FORMULATION; DRUG LABELING; DRUG MIXTURE; ELECTROSPRAY; HIGH PERFORMANCE LIQUID CHROMATOGRAPHY; LIQUID CHROMATOGRAPHY; MASS SPECTROMETRY; SENSITIVITY ANALYSIS; SEPARATION TECHNIQUE;

EID: 78650338283     PISSN: None     EISSN: 19994923     Source Type: Journal    
DOI: 10.3390/pharmaceutics2010050     Document Type: Article

References (34)

1. Dietary Supplements. U.S. Food and Drug Administration. http://www.fda.gov/food/DietarySupplements/default.htm. Accessed on 16 January 2010.
2. Radimer, K.; Bindewald, B.; Hughes, J.; Ervin, B.; Swanson, C.; Picciano, M.F. Dietary supplement use by US adults: data from the National Health and Nutrition Examination Survey, 1999-2000. Am. J. Epidemiol. 2004, 160, 339-349.
3. Radimer, K.L.; Subar, A.F.; Thompson, F.E. Nonvitamin, nonmineral dietary supplements: ssues and findings from NHANES III. J. Am. Diet Assoc. 2000, 100, 447-454.
4. Barnes, P.M.; Bloom, B.; Nahin, R. Complementary and alternative medicine use among adults and children: United States, 2007. Natl. Health Stat. Report. 2008, Dec 10, 1-23.
5. Fariss, M.W.; Nicholls-Grzemski, F.A.; Tirmenstein, M.A.; Zhang, J.G. Enhanced ntioxidant and cytoprotective abilities of vitamin E succinate is associated with a rapid uptake advantage in rat hepatocytes and mitochondria. Free Radic. Biol. Med. 2001, 31, 530-541.
6. Fariss, M.W.; Zhang, J.G. Vitamin E therapy in Parkinson's disease. Toxicology 2003, 189, 129-146.
7. Fraga, C.G. Plant polyphenols: how to translate their in vitro antioxidant actions to in vivo conditions. IUBMB Life 2007, 59, 308-315.
8. Fremont, L. Biological effects of resveratrol. Life Sci. 2000, 66, 663-673.
9. Giovannini, C.; Scazzocchio, B.; Vari, R.; Santangelo, C.; D'Archivio, M.; Masella, R. Apoptosis in cancer and atherosclerosis: polyphenol activities. Ann. Ist. Super. Sanita 2007, 43, 406-416.
10. Roupe, K.; Remsberg, C.; Yanez, J.; Davies, N. Pharmacometrics of Stilbenes: Seguing Towards the Clinic. Curr Clin Pharmacol 2006, 1, 81-101.
11. Remsberg, C.M.; Yanez, J.A.; Ohgami, Y.; Vega-Villa, K.R.; Rimando, A.M.; Davies, N.M. Pharmacometrics of pterostilbene: preclinical pharmacokinetics and metabolism, anticancer, antiinflammatory, antioxidant and analgesic activity. Phytother Res 2008, 22, 169-179
12. Pezet, R.; Pont, V. Mise en evidence de pterostilbene dans les grappes de Vitis vinifera (var. Gamay et Pinot). Plant Physiol. Biochem. 1988, 26, 603-607.
13. Douillet-Breuil, A.C.; Jeandet, P.; Adrian, M.; Bessis, R. Changes in the phytoalexin content of various Vitis spp. in response to ultraviolet C elicitation. J. Agric. Food Chem. 1999, 47, 4456-4461.
14. Adrian, M.; Jeandet, P.; Douillet-Breuil, A.C.; Tesson, L.; Bessis, R. Stilbene content of mature Vitis vinifera berries in response to UV-C elicitation. J. Agric. Food Chem. 2000, 48, 6103-6105.
15. Rimando, A.M.; Kalt, W.; Magee, J.B.; Dewey, J.; Ballington, J.R. Resveratrol, terostilbene, and piceatannol in vaccinium berries. J. Agric. Food Chem. 2004, 52, 4713-4719.
16. Manickam, M.; Ramanathan, M.; Jahromi, M.A.; Chansouria, J.P.; Ray, A.B. Antihyperglycemic activity of phenolics from Pterocarpus marsupium. J. Nat. Prod. 1997, 60, 609-610.
17. An, R.B.; Park, E.J.; Jeong, G.S.; Sohn, D.H.; Kim, Y.C. Cytoprotective constituent of Hoveniae Lignum on both Hep G2 cells and rat primary hepatocytes. Arch. Pharm. Res. 2007, 30, 674-677.
18. Stangl, V.; Lorenz, M.; Ludwig, A.; Grimbo, N.; Guether, C.; Sanad, W.; Ziemer, S.; Martus, P.; Baumann, G.; Stangl, K. The flavonoid phloretin suppresses stimulated expression of endothelial adhesion molecules and reduces activation of human platelets. J. Nutr. 2005, 135, 172-178.
19. Ong, K.C.; Khoo, H.E. Biological effects of myricetin. Gen. Pharmacol. 1997, 29, 121-126.
20. Good, R.L.; Roupe, K.A.; Fukuda, C.; Clifton, G.D.; Fariss, M.W.; Davies, N.M. Direct highperformance liquid chromatographic analysis of D-tocopheryl acid succinate and derivatives. J. Pharm. Biomed. Anal. 2005, 39, 33-38.
21. Russell, A.S.; Aghazadeh-Habashi, A.; Jamali, F. Active ingredient consistency of commercially available glucosamine sulfate products. J. Rheumatol. 2002, 29, 2407-2409.
22. Remsberg, C.M.; Yanez, J.A.; Roupe, K.A.; Davies, N.M. High-performance liquid chromatographic analysis of pterostilbene in biological fluids using fluorescence detection. J. Pharm. Biomed. Anal. 2007, 43, 250-254.
23. Bertram, R.M.; Takemoto, J.K.; Remsberg, C.M.; Vega-Villa, K.R.; Sablani, S.; Davies, N.M. High-performance liquid chromatographic analysis: applications to nutraceutical content and urinary disposition of oxyresveratrol in rats. Biomed. Chromatogr. 2009, doi: 10.1002/bmc.1320.
24. Yanez, J.A.; Davies, N.M. Stereospecific high-performance liquid chromatographic analysis of naringenin in urine. J. Pharm. Biomed. Anal. 2005, 39, 164-169.
25. Yanez, J.A.; Miranda, N.D.; Remsberg, C.M.; Ohgami, Y.; Davies, N.M. Stereospecific highperformance liquid chromatographic analysis of eriodictyol in urine. J Pharm Biomed Anal 2007, 43, 255-262.
26. Yanez, J.A.; Teng, X.W.; Roupe, K.A.; Davies, N.M. Stereospecific high-performance liquid chromatographic analysis of hesperetin in biological matrices. J Pharm Biomed Anal 2005, 37, 591-595.
27. Woody, R.; Fukuda, C.; Roupe, K.; Fariss, M.; Clifton, G.; Davies, N. Alpha-tocopherol Succinate: Analysis, Content Uniformity, Pharmacokinetics, Tissue Distribution and Anti-Cancer Activity. Canadian Society of Pharmaceutical Sciences (CSPS) annual meeting, Vancouver, B.C., Canada, 2004.
28. Feifer, A.H.; Fleshner, N.E.; Klotz, L. Analytical accuracy and reliability of commonly used nutritional supplements in prostate disease. J. Urol. 2002, 168, 150-154; discussion 154.
29. Chua, R.; Anderson, K.; Chen, J.; Hu, M. Quality, labeling accuracy, and cost comparison of purified soy isoflavonoid products. J. Altern. Complement. Med. 2004, 10, 1053-1060.
30. Seeram, N.P.; Henning, S.M.; Niu, Y.; Lee, R.; Scheuller, H.S.; Heber, D. Catechin and caffeine content of green tea dietary supplements and correlation with antioxidant capacity. J. Agric. Food Chem. 2006, 54, 1599-1603.
31. Glisson, J.K.; Rogers, H.E.; Abourashed, E.A.; Ogletree, R.; Hufford, C.D.; Khan, I. Clinic at the health food store? Employee recommendations and product analysis. Pharmacotherapy 2003, 23, 64-72.
32. Draves, A.H.; Walker, S.E. Analysis of the hypericin and pseudohypericin content of commercially available St John's Wort preparations. Can. J. Clin. Pharmacol. 2003, 10, 114-118.
33. Green, G.A.; Catlin, D.H.; Starcevic, B. Analysis of over-the-counter dietary supplements. Clin. J. Sport Med. 2001, 11, 254-259.
34. Nelson, M.H.; Cobb, S.E.; Shelton, J. Variations in parthenolide content and daily dose of feverfew products. Am. J. Health Syst. Pharm. 2002, 59, 1527-1531.